Cognetivity Neurosciences Ltd Revenue and Competitors

London, UK

Location

N/A

Total Funding

Analytics

Industry

Estimated Revenue & Valuation

  • Cognetivity Neurosciences Ltd's estimated annual revenue is currently $2.8M per year.(i)
  • Cognetivity Neurosciences Ltd's estimated revenue per employee is $98,000

Employee Data

  • Cognetivity Neurosciences Ltd has 29 Employees.(i)

Cognetivity Neurosciences Ltd's People

NameTitleEmail/Phone
1
Chief Financial OfficerReveal Email/Phone
2
CEOReveal Email/Phone
3
Head EngineeringReveal Email/Phone
4
VP, Commercial Development; MD Cognetivity FZ LLCReveal Email/Phone
5
AI Compliance Director & DPOReveal Email/Phone
6
Account ManagerReveal Email/Phone
7
Full Stack DeveloperReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.2M22-52%N/AN/A
#2
$16.2M116-6%N/AN/A
#3
$18.3M131-4%$68MN/A
#4
$23.6M15312%N/AN/A
#5
$76.7M438-1%N/AN/A
#6
$3.6M32-11%N/AN/A
#7
$4.6M415%N/AN/A
#8
$7.4M59-16%N/AN/A
#9
$0.6M180%$23MN/A
#10
$1.6M23-38%$4.9MN/A
Add Company

What Is Cognetivity Neurosciences Ltd?

Cognetivity Neurosciences is a medical technology company developing an AI platform for early detection of cognitive impairment, dementia and Alzheimer's disease. Our patented rapid cognitive analysis technology aims to make early detection a reality, and aims to bring the benefits of being: easier to administer, more accessible, less expensive, allowing earlier and more accurate diagnosis.

keywords:N/A

N/A

Total Funding

29

Number of Employees

$2.8M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Cognetivity Neurosciences Ltd News

2022-04-13 - Cognetivity Neurosciences Shines Member-based Spotlight on the Alzheimer's Association Business Consortium

VANCOUVER, BC, April 20, 2022 /CNW/ - Cognetivity Neurosciences Ltd. ("Cognetivity" or the "Company") (CSE: CGN) (OTCQB: CGNSF) (FRA: 1UB),...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.5M29-12%N/A
#2
$4.6M29-6%N/A
#3
$2.9M29-17%N/A
#4
N/A29-24%N/A
#5
$2.4M29-59%N/A